Skip to content

Clinical trials

Cardiomyopathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Canada Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20061
20072
20091
20101
20121
20131
20146
20152
20161
20184
20192
20201
20213
20222
20232
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting7
Unknown status5
Not yet recruiting2
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices5
Alnylam Pharmaceuticals4
Eidos Therapeutics, a BridgeBio company2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
The Hospital for Sick Children2
University of Pittsburgh2
Annetine Gelijns1
Berlin Heart, Inc1
Children's Hospital of Eastern Ontario1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies43
Heart Failure17
Amyloidosis7
Heart Diseases7
Ventricular Dysfunction5
Alzheimer Disease4
Amyloid Neuropathies, Familial3
Amyloidosis, Familial3
Cardiomyopathy, Dilated3
Cardiovascular Diseases3

Trials

Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.